对于老化药物发现的策略
Helen Power1,2,3, Peter Valtchev1,2, Fariba Dehghani1,2
1Faculty of Engineering, School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, New South Wales, Australia.
Aging cell
|August 7, 2023
概括
老化剂是针对细胞衰老的药物,这是衰老和慢性疾病的关键因素. 本综述对已知老化药物和选方法进行了分类,突出了新药发现的潜力.
科学领域:
- 老年病学和药理学
- 细胞生物学和衰老研究研究
背景情况:
- 细胞衰老有助于慢性和与年龄有关的疾病.
- 自2015年以来,老年化药物的领域迅速扩大.
- 老化药物提供了一种治疗策略,以减轻老化相关的病理.
研究的目的:
- 审查和分类已知的老化剂.
- 讨论查和识别新型老年化药物的方法.
- 为了突出最近的进展和 senolytic 药物发现的未来方向.
主要方法:
- 老化剂的分类,包括酶抑制剂,BCL-2抑制剂,多醇等.
- 分析各种查方法,衰老诱导方法,细胞和试验.
- 对单细胞分析和计算识别方法近期进展的回顾.
主要成果:
- 已经确定了广泛的老化药物类别.
- 查方法差异很大,影响结果的质量.
- 强大的查需要经过验证的系统,控制和测试.
结论:
- 在发现新的老化药物方面存在巨大的潜力.
- 对药物点和机制的进一步研究至关重要.
- 严格的临床前和临床评估对于老化疗法是必要的.
相关概念视频
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Structure-Activity Relationships and Drug Design
769
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
769
Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K


